n-acetylneuraminic acid has been researched along with Polyradiculoneuropathy, Chronic Inflammatory Demyelinating in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalakas, MC; Giddens, JP; Keller, CW; Lünemann, JD; Maurer, MA; Münz, C; Nimmerjahn, F; Quast, I; Tackenberg, B; Wang, LX | 1 |
1 trial(s) available for n-acetylneuraminic acid and Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
| Article | Year |
|---|---|
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; B-Lymphocytes; Burkitt Lymphoma; Cell Line, Tumor; Complement C1q; Complement Pathway, Classical; Complement System Proteins; Cytotoxicity, Immunologic; Glycosylation; Humans; Immunoglobulin G; Immunoglobulin gamma-Chains; Immunoglobulins, Intravenous; Killer Cells, Natural; Lymphocyte Depletion; Mice; Myelin-Oligodendrocyte Glycoprotein; N-Acetylneuraminic Acid; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Protein Processing, Post-Translational; Receptors, IgG; Rituximab | 2015 |